UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA

被引：0

作者：

Lassman, Andrew ^{[1
]}

Alexander, Brian ^{[2
]}

Berry, Donald ^{[3
]}

Berry, Nicholas ^{[3
]}

Buxton, Meredith ^{[4
]}

Colman, Howard ^{[5
]}

Gan, Hui ^{[6
]}

de Groot, John ^{[7
]}

de la Fuente, Macarena ^{[8
]}

Drappatz, Jan ^{[9
]}

Ducray, Francois ^{[10
]}

Ellingson, Benjamin ^{[11
]}

Gordon, Gary ^{[4
]}

Hyddmark, Emma ^{[4
]}

Johnson, Adam ^{[4
]}

Khasraw, Mustafa ^{[12
]}

Lee, Eudocia ^{[13
]}

Lim, Michael ^{[14
]}

Mcglothlin, Anna ^{[3
]}

Mellinghoff, Ingo ^{[15
]}

Mikkelsen, Tom ^{[16
]}

Nghiemphu, Phioanh ^{[11
]}

Perry, James ^{[17
]}

Powell, Ashley ^{[4
]}

Sulman, Erik ^{[18
]}

Tanner, Krik ^{[19
]}

Untch, Sarah ^{[4
]}

Weller, Michael ^{[20
,21
]}

Wen, Patrick ^{[13
]}

Wick, Antje ^{[22
]}

Yung, Alfred ^{[23
]}

Cloughesy, Timothy ^{[11
]}

机构：

[1] Columbia Univ, New York Presbyterian Hosp, Herbert Irving Comprehens Canc Ctr, Vagelos Coll Phys & Surg, New York, NY USA

[2] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[3] Berry Consultants LLC, Austin, TX USA

[4] Global Coalit Adapt Res, Larkspur, CA USA

[5] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA

[6] Austin Hlth, Melbourne, Australia

[7] UCSF, San Francisco, CA USA

[8] Univ Miami, Miller Sch Med, Miami, FL USA

[9] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA

[10] CHU Lyon, Lyon, France

[11] UCLA, Los Angeles, CA USA

[12] Duke Univ, Med Ctr, Durham, NC USA

[13] Dana Farber Canc Inst, Boston, MA USA

[14] Stanford Univ, Stanford, CA USA

[15] Mem Sloan Kettering, New York, NY USA

[16] Henry Ford, Detroit, MI USA

[17] Univ Toronto, Toronto, ON, Canada

[18] NYU, Grossman Sch Med, New York, NY USA

[19] Natl Brain Tumor Soc, Newton, MA USA

[20] Univ Hosp, Zurich, Switzerland

[21] Univ Zurich, Zurich, Switzerland

[22] Heidelberg Univ Hosp, Heidelberg, Germany

[23] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

来源：

NEURO-ONCOLOGY | 2024年 / 26卷

关键词：

D O I：

10.1093/neuonc/noae165.0406

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

NOAE165.04

引用

页数：2

共 50 条

[41] Final results of phase 2 trial of personal dendritic cell (DC) vaccines loaded with autologous tumor antigens (ATA) in newly diagnosed glioblastoma (GBM)
Bota, Daniela Annenelie
Piccioni, David Eric
Taylor, Thomas H.
LaRocca, Renato V.
Aiken, Robert D.
Kong, Xiao-Tang
Lopez, Katrina L.
Keirstead, Hans S.
Nistor, Gabriel I.
Dillman, Robert O.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[42] Phase 1b/2a study evaluating the combination of MN-166 (ibudilast) and temozolomide in patients with newly diagnosed and recurrent glioblastoma (GBM).
Youssef, Gilbert
Lathia, Justin
Lee, Eudocia Quant
Chukwueke, Ugonma Nnenna
Lauko, Adam
Batchelor, Tracy
Aquilanti, Elisa
Nayak, Lakshmi
Myers, Alexa
Russ, Alyssa
Westergaard, Catharina C.
Alban, Tyler
Jarmula, Jakub
Lee, Juyeun
Vogelbaum, Michael A.
Matsuda, Kazuko
Reardon, David A.
Wen, Patrick Y.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[43] AVAglio: Phase 3 Trial of Bevacizumab Plus Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
Chinot, O. L.
Rouge, T. de la Motte
Moore, N.
Zeaiter, A.
Das, A.
Phillips, H.
Modrusan, Z.
Cloughesy, T.
ADVANCES IN THERAPY, 2011, 28 (04) : 334 - 340
[44] AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme
O. L. Chinot
T. de La Motte Rouge
N. Moore
A. Zeaiter
A. Das
H. Phillips
Z. Modrusan
T. Cloughesy
Advances in Therapy, 2011, 28 : 334 - 340
[45] Hypofractionated accelerated radiotherapy (HART) with concurrent and maintenance temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM)
Mallick, Supriya
Haresh, K. P.
Gupta, Subhash
Sharma, Seema
Laviraj, M. A.
Upadhyay, Ashish Dutt
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[46] A Combined Phase 0/2 "Trigger" Trial Evaluating Pamiparib or Olaparib with Concurrent Radiotherapy in Patients with Newly-Diagnosed or Recurrent Glioblastoma
Kennedy, W. R.
Chang, Y. W.
Jiang, J.
Molloy, J.
Pennington-Krygier, C.
Harmon, J.
Hong, A.
Wanebo, J.
Braun, K.
Garcia, M. A.
Barani, I. J., Jr.
Yoo, W.
Tovmasyan, A.
Tien, A. C.
Li, J.
Mehta, S.
Sanai, N.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E115 - E115
[47] Phase 3 study comparing radiotherapy with supportive care in older patients with newly diagnosed anaplastic astrocytomas (AA) or glioblastoma multiforme (GBM):: An ANOCEF group trial
Keime-Guibert, F
Chinot, O
Taillandier, L
Cartalat-Carel, S
Frenay, M
Kantor, G
Guillamo, J
Jadaud, E
Colin, P
Bondiau, P
Meneï, P
Loiseau, H
Bernier, V
Mazeron, J
Honnorat, J
Barrié, M
Bissery, A
Delattre, J
NEURO-ONCOLOGY, 2005, 7 (03) : 349 - 349
[48] PHASE I/II STUDY TO EVALUATE THE SAFETY AND CLINICAL EFFICACY OF ATEZOLIZUMAB (ATEZO) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) AND RADIATION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
Weathers, Shiao-Pei
Kamiya-Matsuoka, Carlos
Harrison, Rebecca
Liu, Diane
Sanqui, Edmund
Dervin, Shannon
Yun, Cindy
Loghin, Monica
Penas-Prado, Marta
Majd, Nazanin
Yung, W. K. Alfred
O'Brien, Barbara
de Groot, John
NEURO-ONCOLOGY, 2020, 22 : 35 - 35
[49] Evaluating the benefit of adaptive randomization in the CC-115 arm of the Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A phase II randomized Bayesian adaptive platform trial in newly diagnosed MGMT unmethylated glioblastoma.
Rahman, Rifaquat
Trippa, Lorenzo
Fell, Geoffrey
Lee, Eudocia Quant
Arrillaga-Romany, Isabel
Touat, Mehdi
Drappatz, Jan
Galanis, Evanthia
Ahluwalia, Manmeet Singh
Colman, Howard
Nabors, Louis B.
Hepel, Jaroslaw T.
Schiff, David
Welch, Mary Roberta
Meredith, David M.
Chiocca, E. Antonio
Reardon, David A.
Ligon, Keith L.
Alexander, Brian Michael
Wen, Patrick Y.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[50] Phase 2 study to evaluate safety and efficacy of MEDI4736 (durvalumab [DUR]) in glioblastoma (GBM) patients: An update.
Reardon, David A.
Kaley, Thomas Joseph
Dietrich, Jorg
Clarke, Jennifer Leigh
Dunn, Gavin P.
Lim, Michael
Cloughesy, Timothy Francis
Gan, Hui Kong
Park, Andrew J.
Schwarzenberger, Paul
Ricciardi, Toni
Macri, Mary J.
Ryan, Aileen
Venhaus, Ralph Rudolph
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35

← 1 2 3 4 5 →